Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.66
-0.25 (-27.68%)
Market open: Aug 12, 2026, 11:30 AM EDT
0.91
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
| Name | Position |
|---|---|
| Mr. Jeffrey Frelick | CEO & President |
| Ms. Deina H. Walsh CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-07-23 | 8-K | form8-k.htm |
| 2026-07-20 | DEFA14A | formdefa14a.htm |
| 2026-07-17 | S-3 | forms-3.htm |
| 2026-07-16 | 8-K | form8-k.htm |
| 2026-07-09 | 8-K | form8-k.htm |
| 2026-07-02 | DEFA14A | formdefa14a.htm |
| 2026-07-02 | DEF 14A | formdef14a.htm |
| 2026-05-14 | 10-Q | form10-q.htm |
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-03-02 | 10-K | form10-k.htm |